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INTRODUCTION
Thyroglossal duct remnants represent a common developmental 
abnormality of the thyroid gland, and thyroglossal duct carcino-
ma (TGDC) reportedly occurs in approximately 1% of all thyro-
glossal duct remnants [1,2]. The incidence of lymph node metas-
tases in papillary carcinoma of TGDC is rare (7% to 15%), 
compared with the incidence in primary papillary thyroid carci-
noma [3]. 
 Carotid body tumors (CBTs) are rare, benign neoplasms that 
originate from the neuroectodermal paraganglion. Originating 
from the afferent ganglion of the glossopharyngeal nerve, carot-
id body tumors are generally located at the carotid bifurcation 
[4]. Physiological activity is rare in these neoplasms, and these 
tumors generally exhibit a slow rate of growth, most often pre-
senting asymptomatically as a space-occupying mass lesion not-
ed clinically or radiographically [4,5]. To our knowledge, TGDC 
with neck metastasis accompanied by a CBT has not been re-
ported previously. In addition, the CBT in the present case mim-
icked neck metastasis from the TGDC. We present a case of the 
CBT mimicking neck metastasis from the TGDC with a review 
of literature.
CASE REPORT
A 78-year-old woman visited our clinic, presenting with a 3-year 
history of a midline neck mass in the region of the hyoid bone 
and bilateral cervical asymptomatic neck masses. There were no 
constitutional symptoms, including fever, night sweating, fatigue, 
dysphagia, dyspnea, and weight loss. She reported that the mass 
was progressively increasing in size. The rest of the history was 
unremarkable. Physical examination showed a 3×3-cm rubbery, 
non-tender, semi-fixed midline mass and several enlarged lymph 
nodes at level II and III bilaterally. There were no pulsations or 
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bruits on auscultation of the lateral neck masses. The results of 
routine laboratory tests, including blood chemistry, complete 
blood cell count, coagulation study, serologic testing, and urine 
analysis, were unremarkable. Electrocardiogram and chest X-ray 
were within normal limits.
 Computed tomography (CT) with contrast showed an irregu-
larly marginated, round, heterogeneously enhancing mass at the 
level of the hyoid bone and multiple enlarged lymph nodes bi-
laterally at level II to III (Fig. 1A). Interestingly, the left-side neck 
mass was located at the carotid bifurcation, splaying the carotid 
bifurcation on a CT scan (Fig. 1B). However, the CT scan did 
not indicate other instances of abnormal lymphadenopathy in 
the left neck. Furthermore, neck CT and sonography did not 
demonstrate any mass involving the thyroid (Fig. 1C). Fine nee-
dle aspiration biopsy (FNAB) was done on the midline mass and 
right-side neck mass. The results of FNAB suggested the possi-
bility of papillary carcinoma and lymph node metastasis from 
papillary carcinoma, respectively. From the above results, we 
made the tentative diagnosis of TGDC carcinoma with bilateral 
neck metastasis. We planned to resect the masses, including bi-
lateral neck dissection, in accordance with TGDC with neck me-
tastasis. Splaying of the carotid bifurcation, however, is usually 
indicative of a CBT. Through the head and neck tumor board, 
we decided that carotid arteriography should be preoperatively 
performed to differentiate a CBT from lymph node metastasis. 
The mass was confirmed as a highly vascular mass in the bifur-
cation of the carotid artery that was compressing the internal 
and external carotid arteries (Fig. 1D). Ascending pharyngeal ar-
tery represented the major blood supply for this tumor. Our pa-
tient did not undergo carotid occlusion testing and embolization 
because of the potential complications. Results of screening for 
metanephrine and vanillymandelic acid in 24-hour urine sam-
ples were negative.
 Subsequently, the patient underwent wide excision of the 
midline neck mass, including resection of the hyoid bone, total 
thyroidectomy, central neck dissection and right-side selective 
neck dissection (levels II-V), involving resection of the sterno-
cleidomastoid muscle, spinal accessory nerve, and internal jugu-
lar vein. Although there was mild adhesion between the midline 
mass and surrounding soft tissue, we obtained a generous resec-
tion margin (Fig. 2A, B). During the exploration of left-side 
neck, we confirmed the CBT between external and internal ca-
rotid artery (Fig. 2C). We did not try to remove the left-side neck 
mass (CBT) because it had a tendency to bleed when touched 
and the patient was elderly. 
 Histological analysis revealed that a thyroglossal duct cyst was 
Fig. 1. Axial view of a computed tomography scan with contrast show-
ing a round heterogeneously enhanced mass with irregular margins 
at the level of the hyoid bone with multiple enhanced, enlarged cer-
vical lymph nodes on the right, at level II (A). Note that a highly en-
hanced mass was located at the carotid bifurcation (B). There was 
no abnormal lesion in the thyroid gland (C). Carotid arteriography 
demonstrated a highly vascular mass at the bifurcation of the carot-




Fig. 2. Photograph of the intraoperative findings showing the surgi-
cal field of the right side of the neck after the completion of modified 
neck dissection (A). Surgical specimens showing the en bloc speci-
men of the neck dissection and thyroglossal duct carcinoma and to-
tal thyroidectomy specimen (B). Note that the CBT was located be-
tween the internal and external arteries, splaying the carotid bifurca-
tion (C). P, primary tumor; LN, metastatic lymph nodes; T, thyroid 
gland; SMG, submandibular gland; CBT, carotid body tumor; ICA, 









Kim JW et al. Coexistence of a Carotid Body Tumor and Thyroglossal Duct Carcinoma    71
lined by a single row of columnar epithelium and the tumor was 
composed of small and large papillary structures with fibrovas-
cular cores (Fig. 3A, B). In addition, the tumor cells lining the 
papillary structures of the midline mass and cervical lymph 
nodes showed nuclear grooves and nuclear clearing, which are 
characteristic nuclear features of papillary carcinoma (Fig. 3C, 
D). The final histopathologic diagnosis was consistent with 
TGDC papillary carcinoma with perithyroidal soft tissue exten-
sion and subsequent multiple lymph node metastasis (17 out of 
55 lymph nodes). However, we could not demonstrate any evi-
dence of papillary carcinoma in the thyroid gland. 
 The patient refused adjuvant therapy with 131I after surgery 
and was only treated with levothyroxine supplementation. At 
the 2-year follow-up, the patient remained free of disease.
DISCUSSION
Although a thyroglossal duct remnant is the most common con-
genital midline neck mass, TGDC is thought to be extremely rare, 
occurring in approximately 1% of all diagnosed thyroglossal 
duct remnants [1,2].
 CBT is a rare paraganglioma located near the bifurcation of 
the common carotid artery. The most common presentation is 
the development of an asymptomatic lateral neck mass without 
a thrill or bruit. Cranial nerve deficits are uncommon but may 
be seen in patients with masses greater than 5 cm in diameter [4, 
5]. In the present case, the patient had no specific symptom ex-
cept multiple neck masses. 
 On the rare occasion when TGDC is suspected clinically, pre-
operative physical examination, sonography, CT, MRI, and FNA 
may be helpful [6]. On physical examination, a neck mass that 
moves with swallowing and tongue movement is characteristic. 
The most common CT findings of TGDC are a solid nodule in 
the cyst, followed by calcification, an irregular margin, and a 
thick wall [7,8]. These findings, except calcification, correspond-
ed to those in the present case. Furthermore, the CT scan in the 
present case demonstrated multiple conglomerated lymphade-
nopathies, suggestive of malignancy, and FNAB of the midline 
and right-side neck masses indicated the possibility of papillary 
carcinoma. 
 In CBT, either contrast-enhanced CT or MRI will clearly dem-
onstrate a paraganglioma expanding the carotid bifurcation. The 
diagnosis of CBT is generally confirmed by carotid arteriogra-
phy that shows a highly vascular tumor enlarging the space be-
tween the internal and external carotid arteries [5]. However, it 
was easier to overlook the possibility of a CBT in the present 
case for the preoccupation of neck metastasis from TGDC. Con-
sidering the splaying of the carotid bifurcation revealed by the 
CT scan, we fortunately suspected the possibility of left-side 
CBT. Carotid arteriography was performed to differentiate be-
tween CBT and lymph node metastasis. 
 Widstrom et al. [9] described three definitive criteria for dis-
tinguishing between primary TGDC and metastatic disease from 
a primary lesion inside the thyroid gland. First, the carcinoma 
should be in the wall of the thyroglossal duct cyst. Second, the 
TGDC must be differentiated from a cystic lymph node metas-
tasis by histological demonstration of a squamous or columnar 
epithelial lining and normal thyroid follicles in the wall of the 
thyroglossal duct cyst. Third, malignancy should not be present in 
the thyroid gland or any other possible primary site. These crite-
ria corresponded to the pathologic findings in the present case. 
 The nonfamilial association of carotid body tumors and papil-
lary carcinomas of the thyroid was first described in 1968 [10]. 
It is unclear that whether there is a common pathogenesis for 
carotid body tumors and differentiated thyroid carcinomas, but 
Larraza-Hernandez et al. [11] and Kuratomi et al. [12] reported 
differentiated thyroid carcinomas associated with carotid body 
tumors. Because TGDC accompanied by a CBT has not been 
reported previously, it is necessary to search for TGDC as well 
as carotid body tumors in order to learn more about this associ-
ation.
 The most frequently used surgical therapeutic approach for 
TGDC is the Sistrunk procedure, which includes en-bloc resec-
tion of the thyroglossal duct cyst along with the tract, the mid-
dle part of the hyoid bone, and the soft tissues along the course 
of the thyroglossal duct to the level of the foramen cecum. The 
incidence of cervical lymph node metastasis from TGDC has 
been reported to be 7 to 15% [3]. When cervical lymph node 
metastasis is present, a reasonable approach is to perform a 
Fig. 3. Histopathologic findings. A thyroglossal duct cyst lined by a 
single row of columnar epithelium (H&E, ×40) (A). The tumor was 
composed of small and large papillary structures with fibrovascular 
cores (H&E, ×100) (B). The tumor cells lining the papillary struc-
tures showed nuclear grooves and nuclear clearing, which are char-
acteristic nuclear features of papillary thyroid carcinoma. The nuclei 
showed a thick, irregular nuclear membrane, a high nuclear/cyto-
plasmic ratio, and somewhat eccentric nucleoli (H&E, ×400) (C). A 
lymph node showing subcapsular sinusoidal metastatic carcinoma. 
The histological appearance of the metastatic carcinoma is the 
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Sistrunk procedure, a total thyroidectomy, and selective neck 
dissection at an appropriate level [13].
 CBTs are best treated by subadventitial resection. The most 
common complications of surgical resection are stroke and cra-
nial nerve injury. Accordingly, for asymptomatic elderly patients, 
the indolent nature of CBTs has led to the recommendation of 
surveillance [14]. In our case, the patient underwent wide exci-
sion of the midline neck mass, including resection of the hyoid 
bone, total thyroidectomy, central neck dissection and selective 
neck dissection (levels II-V). However, we left the CBT unre-
sected because we surmised that this CBT would not influence 
the life expectancy of this patient.
 In TGDC, additional therapy is indicated if there is involve-
ment of the thyroid gland, soft tissue invasion, or lymph node 
metastases. Ablation-dose radioactive iodine should follow, with 
subsequent scanning to exclude further tumor foci, as is standard 
practice for the majority of well-differentiated thyroid carcino-
mas [15]. The prognosis of TGDC is generally excellent, given 
adequate treatment. 
 Few reports about TGDC or CBT are present in the literature, 
and this is the first reported case involving the coexistence of 
TGDC with neck metastasis and CBT. Moreover, the CBT in 
the present case mimicked neck metastasis from the TGDC. If 
we had missed the possibility of CBT in the left-side neck mass, 
we would likely have encountered unexpected bleeding from 
the tumor and adhesion between the tumor and carotid artery 
during the left-side neck dissection. The present case demon-
strates the importance of performing a careful physical exami-
nation and thorough evaluation of preoperative imaging studies 
before initiating surgical treatment of various head and neck tu-
mors.
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